These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15590419)

  • 21. Hepatocyte growth factor and c-Met immunoreactivity are associated with metastasis in high grade salivary gland carcinoma.
    Tsukinoki K; Yasuda M; Mori Y; Asano S; Naito H; Ota Y; Osamura RY; Watanabe Y
    Oncol Rep; 2004 Nov; 12(5):1017-21. PubMed ID: 15492787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoexpression of the hepatocyte growth factor (HGF), HGF-receptor (c-met) and STAT3 on placental tissues from malformed fetuses.
    Trovato M; Grosso M; Vitarelli E; Benvenga S; Trimarchi F; Barresi G
    Histol Histopathol; 2002; 17(3):691-8. PubMed ID: 12168776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the c-Met receptor complex in fibroblasts drives invasive cell behavior by signaling through transcription factor STAT3.
    Cramer A; Kleiner S; Westermann M; Meissner A; Lange A; Friedrich K
    J Cell Biochem; 2005 Jul; 95(4):805-16. PubMed ID: 15838885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death.
    Wislez M; Rabbe N; Marchal J; Milleron B; Crestani B; Mayaud C; Antoine M; Soler P; Cadranel J
    Cancer Res; 2003 Mar; 63(6):1405-12. PubMed ID: 12649206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue.
    Fluge Ø ; Haugen DR; Lillehaug JR; Varhaug JE
    World J Surg; 2001 May; 25(5):623-31. PubMed ID: 11369990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and localization of hepatocyte growth factor and its receptor c-Met in inverted papillomas.
    Choi JH; Lee SH; Lee HM; Lee SH; Jung HH; Choi J; Lim HW; Lee SW; Kang SM
    Acta Otolaryngol; 2006 Jul; 126(7):724-9. PubMed ID: 16803712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of hepatocyte growth factor and c-MET expression in patients with diffuse large B-cell lymphoma.
    Kawano R; Ohshima K; Karube K; Yamaguchi T; Kohno S; Suzumiya J; Kikuchi M; Tamura K
    Br J Haematol; 2004 Nov; 127(3):305-7. PubMed ID: 15491290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of hepatocyte growth factor and its receptor c-Met in nasal polyps.
    Rho HS; Lee SH; Lee HM; Lee SH; Jung HH; Choi J; Park MK; Kang SM
    Arch Otolaryngol Head Neck Surg; 2006 Sep; 132(9):985-9. PubMed ID: 16982975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
    Takeda K; Kinoshita I; Shimizu Y; Ohba Y; Itoh T; Matsuno Y; Shichinohe T; Dosaka-Akita H
    BMC Cancer; 2008 Nov; 8():328. PubMed ID: 18992165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.
    Kim CH; Moon SK; Bae JH; Lee JH; Han JH; Kim K; Choi EC
    Acta Otolaryngol; 2006 Jan; 126(1):88-94. PubMed ID: 16308260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas.
    Harvey P; Warn A; Newman P; Perry LJ; Ball RY; Warn RM
    J Pathol; 1996 Dec; 180(4):389-94. PubMed ID: 9014859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
    Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of hepatocyte growth factor and its receptor c-met, correlates with severity of pathological injury in experimental alcoholic liver disease.
    Lalani el-N; Poulsom R; Stamp G; Fogt F; Thomas P; Nanji AA
    Int J Mol Med; 2005 May; 15(5):811-7. PubMed ID: 15806303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid.
    Zanetti A; Stoppacciaro A; Marzullo A; Ciabatta M; Fazioli F; Prat M; Comoglio PM; Baroni CD; Ruco LP
    J Pathol; 1998 Nov; 186(3):287-91. PubMed ID: 10211118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte growth factor; expression, concentration and biological activity in chronic leg ulcers.
    Nayeri F; Olsson H; Peterson C; Sundqvist T
    J Dermatol Sci; 2005 Feb; 37(2):75-85. PubMed ID: 15659325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of hepatocyte growth factor and c-MET in skull base chordoma.
    Naka T; Kuester D; Boltze C; Scheil-Bertram S; Samii A; Herold C; Ostertag H; Krueger S; Roessner A
    Cancer; 2008 Jan; 112(1):104-10. PubMed ID: 17948912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma.
    Osada S; Kanematsu M; Imai H; Goshima S
    Hepatogastroenterology; 2008; 55(82-83):544-9. PubMed ID: 18613405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.